IMO & Yael Re-up in Drug Discovery
18 Feb 2025
US$ 20.00
IMO Ventures and Yael Capital, both headquartered in the US, have made a follow-on investment in the series A1 ......
Related Publications
After successfully winning the two-year-long bidding war with Crescent Capital Partners over the privatisation of ......
Savvy foreign investors are seeking to strengthen their footholds in South Korea where domestic private equity firms ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.